Vir Biotechnology (VIR) Operating Income (2018 - 2025)
Historic Operating Income for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to -$173.4 million.
- Vir Biotechnology's Operating Income rose 2501.51% to -$173.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$548.6 million, marking a year-over-year increase of 992.95%. This contributed to the annual value of -$587.2 million for FY2024, which is 1419.54% up from last year.
- Per Vir Biotechnology's latest filing, its Operating Income stood at -$173.4 million for Q3 2025, which was up 2501.51% from -$118.4 million recorded in Q2 2025.
- In the past 5 years, Vir Biotechnology's Operating Income registered a high of $1.0 billion during Q1 2022, and its lowest value of -$231.3 million during Q3 2024.
- Its 5-year average for Operating Income is -$23.6 million, with a median of -$139.5 million in 2025.
- Data for Vir Biotechnology's Operating Income shows a peak YoY increase of 73910.28% (in 2022) and a maximum YoY decrease of 46911.35% (in 2022) over the last 5 years.
- Over the past 5 years, Vir Biotechnology's Operating Income (Quarter) stood at $571.8 million in 2021, then crashed by 126.32% to -$150.5 million in 2022, then increased by 7.63% to -$139.0 million in 2023, then grew by 15.73% to -$117.2 million in 2024, then tumbled by 48.05% to -$173.4 million in 2025.
- Its last three reported values are -$173.4 million in Q3 2025, -$118.4 million for Q2 2025, and -$139.5 million during Q1 2025.